COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02282020
Brief Title: Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments (SOLO3)

First Submitted : October 20, 2014
First Submitted that Met QC Criteria : October 31, 2014
First Posted : November 4, 2014 (Estimate)

Results First Submitted : October 3, 2019
Results First Submitted that Met QC Criteria : November 27, 2019
Results First Posted : December 2, 2019

Last Update Submitted that Met QC Criteria : June 15, 2020
Last Update Posted : June 30, 2020